| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |